Generalized Myasthenia Gravis (gMG) research hub
3 indexed studies · 3 currently recruiting
- recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants with Generalized Myasthenia Gravis (gMG)
This study is looking into a new treatment called Batoclimab for adults with a muscle weakness condition called generalized Myasthenia Gravis (gMG). It wants to see if the treatment helps improve daily activities and if it's safe to use.
Romania · Germany · Italy - recruitingTherapeutic confirmatory (Phase III)
ARGX-113-2003: A Phase 3B, Randomized, Open-Label, Parallel-Group Study to Evaluate Different Dosing Regimens of Intravenous Efgartigimod to Maximize and Maintain Clinical Benefit in Patients With Generalized Myasthenia Gravis
This study is looking at different ways to give a drug called efgartigimod (Vyvgart) to people with generalised myasthenia gravis (gMG). We want to find out the best way to give the treatment to help people feel better and improve their symptoms.
Spain · Italy · Austria - recruiting
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
This study looks at the safety of Ultomiris (a medicine) during pregnancy and breastfeeding. It checks for any effects on the pregnant person and the baby, from before birth up to the baby's first birthday. It’s for people who have already used Ultomiris.
United States · Australia · France